Subsequently, HSP60 downregulation facilitated RKIP-mediated inactivation of the MAPK signaling pathway, thereby enhancing lenvatinib sensitivity and suppressing immune evasion in HCC. Here, HSPD1 is linked to hepatocellular carcinoma.